1. Issues in the Conduct of Economic Evaluations of Pharmaceutical Products

   • Michael F. Drummond

   Guest Editorial 30 November 2012 Pages: 405 - 411

2. Implementing Pharmacoeconomic Outcomes Management

   • William F. McGhan
   • Becky A. Briesacher

   Guest Editorial 30 November 2012 Pages: 412 - 416

3. A Comparative Analysis of the Pharmaceutical Market in Four European Countries

   • Livio Garattini
   • Franco Salvioni
   • Silvio Garattini

   Leading Article 30 November 2012 Pages: 417 - 423

4. Pharmaceutical Prices, Quantities and Innovation

   • Naoki Ikegami
   • Will Mitchell
   • Joan Penner-Hahn

   Review Article 30 November 2012 Pages: 424 - 433

5. Quality-of-Life Assessment of Adults with Growth Hormone Deficiency

   • Stephen P. McKenna
   • Lynda C. Doward

   Review Article 30 November 2012 Pages: 434 - 441

6. Cost of Treatment and Prevention of Haemophilus influenzae Type b Disease

   • Dennis A. Clements

   Review Article 30 November 2012 Pages: 442 - 452

7. Chemonucleolysis versus Surgical Discectomy for Sciatica Secondary to Lumbar Disc Herniation*

   • Robert Launois
   • Bernadette Henry
   • Jean-Marie Goehrs

   Original Research Article 30 November 2012 Pages: 453 - 463

8. Economic Evaluation of Immunoprophylaxis in Children with Recurrent Ear, Nose and Throat Infections

   • Kurt Banz
   • David Schwicker
   • Anne Marie Thomas

   Original Research Article 30 November 2012 Pages: 464 - 477

9. Expert Systems

   • David Nash
   • Paul E. Windt
   • Andrew M. Peterson

   Current Comment 30 November 2012 Pages: 478 - 479

10. Generic Competition in Canada

    • John W. Steele

    Current Comment 30 November 2012 Pages: 480 - 482

11. Infection After Surgery for Gastrointestinal Cancer

    • S. Ragnar Norrby

    Current Comment 30 November 2012 Pages: 483 - 484

12. Clarifying the Costs of Theophylline Toxicity

    • Arthur S. Zbrozek

    Letter to the Editor 30 November 2012 Pages: 485 - 485